Akash Patil

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

Cell death discovery

Oncoimmunology

Research square

Johns Hopkins University (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Johns Hopkins University Aug 30 2018

United States

MSC :: Biomedical Engineering

Georgia Institute of Technology Aug 01 2012 - Aug 01 2016

United States

BSC :: Biomedical Engineering

Publications

Natsuki Furukawa, Wendy Yang, Alex R Chao, Akash Patil, Adam C Mirando, Niranjan B Pandey, Aleksander S Popel
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth. Cell death discovery 10 (1) (2024)
Natsuki Furukawa, Wendy Yang, Alex R Chao, Akash Patil, Adam C Mirando, Niranjan B Pandey, Aleksander S Popel
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth. Cell death discovery 10 (1) (2024)
Natsuki Furukawa, Wendy Yang, Alex R Chao, Akash Patil, Adam C Mirando, Niranjan B Pandey, Aleksander S Popel
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth. Cell death discovery 10 (1) (2024)
Natsuki Furukawa, Wendy Yang, Alex R Chao, Akash Patil, Adam C Mirando, Niranjan B Pandey, Aleksander S Popel
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth. Cell death discovery 10 (1) (2024)
Natsuki Furukawa, Wendy Yang, Alex Chao, Akash Patil, Adam Mirando, Niranjan Pandey, Aleksander Popel
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth. Research square (2023)
Adam C Mirando, Akash Patil, Christine I Rafie, Brian J Christmas, Niranjan B Pandey, Vered Stearns, Elizabeth D Thompson, Evanthia T Roussos Torres, Aleksander S Popel
Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide. Oncoimmunology 9 (1) (2020)

Akash Patil.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Akash Patil